AI adoption has surged from 45% in the finance sector in 2022 to a projected 85% by 2025, with 60% of businesses already leveraging AI across multiple functions. This rapid integration of AI extends ...

I wore the world's first HDR10 smart glasses TCL's new E Ink tablet beats the Remarkable and Kindle Anker's new charger is one of the most unique I've ever seen Best laptop cooling pads Best flip ...

One chapter of the 2025-26 UEFA Women's Champions League new era closes, and another opens. All 18 teams participated in the final matchday of the league phase on Wednesday, with simultaneous kickoffs ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Cylembio plus pembrolizumab achieved a clinically relevant 19.4 months median progression free survival (mPFS) compared to 11.0 months mPFS with pembrolizumab alone; study narrowly missed progression ...

NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines, today ...

Privacy-focused consumer tech company DuckDuckGo launched a subscription plan last year that bundled a VPN service, personal information removal, and identity theft ...

Patients treated with Cylembio (imsapepimut and etimupepimut, adjuvanted) plus pembrolizumab achieved improvement in progression free survival (PFS) compared to patients treated with pembrolizumab ...

Discover how IO-Link-enabled piezoelectric vibration sensors are transforming machine health monitoring offering deeper insights, fewer installation hurdles, and smarter maintenance decisions for ...

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT) today announces topline results from the pivotal Phase 3 trial of its investigational, immune-modulatory, off-the-shelf ...

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Sign up for our newsletter to get the latest on the transformative ...